Inventors:
Mitchell J. Melling - Beaver UT, US
Wade M. Melling - Beaver UT, US
International Classification:
A61K 39/00, A61P 37/06, A61K 38/36, C07K 7/06, C07K 7/08
US Classification:
4241851, 530329, 530328, 530327, 530326, 514 136
Abstract:
A group of peptides has been isolated from the serum of domesticated mammals and then identified through the use of mass spectrometry. These peptides are byproducts of fibrinogen activation and the complement cascade. The peptides of greatest activity are the activated forms of fibrinopeptide A and fibrinopeptide B {activated by the removal of the terminal Arginine), and an immunomodulatory fragment of Complement Component 3. These form of fibrinopeptides A and B have remarkable immunomodulatory ability, enhancing recognition of foreign substances including infectious agents of all types, decreasing the inflammatory response, preventing the deposition of extravascular fibrin, stimulating the resorption of fibrin that has already been deposited, enhancing the body's ability to recognize and eliminate neoplastic cells, decreasing symptoms of allergic reaction including allergic rhinitis and anaphylaxis, decrease the formation and deposit of autoantibody complexes, ameliorate the symptoms of chronic neurologic disease, and decrease the symptoms of chronic pain syndromes.